M. Viguier a, T. Casale b, M. Maurer c, H.J. Hsieh d, J. Canvin e, S. Saini f, C. Grattan g, A. Gimenez-Arnau h, A. Kaplan i, K. Rosen d
a Service de dermatologie, hôpital Saint-Louis, Paris, France
b Creighton University Medical Center, Omaha, Nebraska, États-Unis
c Department of dermatology and allergology, Charité-Universitätsmedizin, Berlin, Allemagne
d Genentech Inc., South San Francisco, États-Unis
e Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, Royaume-Uni
f Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, États-Unis
g Department of dermatology, Norfolk and Norwich University Hospitals, Norwich, Royaume-Uni
h Department of dermatology, Hospital del Mar, Universitat Autonoma, Barcelona, Espagne
i Medical University of South Carolina, Charleston, South Carolina, États-unis